Tag: Talaris

UofL-born company secures an additional $115 million to advance cell therapy...

A company born at the University of Louisville has raised an additional $115 million to further develop a therapy that could improve the lives...

UofL-born cell therapy for organ transplants enters Phase 3 trial First...

A cell therapy born at the University of Louisville that could improve the lives of kidney transplant recipients has entered its Phase 3 clinical...

UofL-born company secures $100 million to advance cell therapy

A company born at the University of Louisville has raised $100 million from investors to develop a therapy, based on UofL research, that could...